Saudi Arabia Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

Description

Saudi Arabia Infection Control Market Size:

Saudi Arabia infection control market is anticipated to expand at a high CAGR over the forecast period.

The market is estimated to continue to grow in the forecast period, with the evolving healthcare landscape of the country. The growing health privatization with the intent to reduce dependence on the public sector is providing an opportunity for the market to increase at a rapid pace over the next five years. The significant contribution of the healthcare sector to the national GDP is proving to contribute to the growth of the healthcare industry, further creating strong market growth prospects during the forecast period. The growing number of hospital beds in all the hospitals in the country is further projected to drive market growth in the forecast period and the upcoming years. The growth of the pharmaceutical industry in the Kingdom of Saudi Arabia, coupled with the growing domestic manufacturing base, is estimated to augment the market growth in the upcoming years.

Saudi Arabia Infection Control Market Overview & Scope

The Saudi Arabia infection control market is segmented by:

• Product: The low-temperature sterilization segment, which is going to have the highest growth rate in the Saudi Arabian market, is the one that has been recently introduced in the medical field. The primary reason for this trend is the considerable surge in the usage of complicated and heat-sensitive medical instruments in the country, for instance, endoscopes and advanced surgical devices, which cannot tolerate high temperatures. The main factors for its consumption are the technological progress and patient safety requirements that continue to rise.
• Application: Pharmaceutical and biotechnology manufacturing is the highest-growing segment. The Kingdom of Saudi Arabia is putting a lot of money into local pharma and biotech production as part of its Vision 2030 plan to decrease import dependency. This development generates a huge demand for modern sterilization and cleanroom infection control solutions.
• End-User Industry: The healthcare sector is the biggest and most rapidly growing end-user segment. The main factors behind this are the increasing hospital admissions, government spending on health care infrastructure as part of the Saudi Vision 2030, and the implementation of more stringent regulations for infection prevention in hospitals and clinics. The rising number of surgical procedures, medical tourism, and growing infection awareness are supporting the demand growth.

Top Trends Shaping the Saudi Arabia Infection Control Market

1. Growing Healthcare Privatization
   At present, public spending is still dominating in the country. However, significant efforts are being made in the expansion of privatization of government services in the healthcare sector as well, which will drive the market demand in the forecast period and the upcoming years. The Saudi government is promoting privatization in the country to reduce the country's reliance on the public sector. The objectives include the expansion of the role of the private sector, increasing the number of licensed medical facilities, and doubling the number of primary care centres per capita visits from two to four, among other objectives. Such initiatives will further surge the market growth in the forecast period and the upcoming years.

Saudi Arabia Infection Control Market Growth Drivers vs. Challenges

Drivers:

• The Growing Pharmaceutical Sector: Significant initiatives for the domestic manufacturing of pharmaceutical products are poised to augment the market demand in the upcoming years. Also, as per the government plan, the local manufacturing base of pharmaceuticals will promote technology transfer, conduct clinical trials in Saudi Arabia, and train the Saudi labour force. The 2030 Vision and National Transformation Program are set to develop five industrial sectors, which include the pharma and biotech industries as well.
• Increased Hospital-Acquired Infection (HAI) Burden: Hospital-acquired infections continue to be a big problem in healthcare facilities in Saudi Arabia. A rise in the number of surgeries, ICU admissions, and invasive procedures has escalated the chances of HAIs that include bloodstream infections, pneumonia, and surgical site infections. As per worldwide health statistics, hospital-acquired infections have the potential to prolong hospital stays, elevate treatment expenses, and cause a higher death rate. Consequently, hospitals in Saudi Arabia are under intense regulatory pressure to put in place effective infection prevention measures, which is the main reason for the rising demand for disinfectants, sterilizers, and contract sterilization services.

Challenges:

• Advanced Infection Control Technologies Are Expensive: Modern sterilizing machines, automated UV disinfection robots, and cutting-edge low-temperature sterilizers not only incur huge capital costs but also substantial operational costs. Several medium-sized hospitals, small clinics, and local pharmaceutical manufacturers in Saudi Arabia face the problem of these solutions being out of their reach due to their high prices. The expenses involved do not just stop at the purchase price, as there will also be recurring costs for consumables, regular maintenance, and compliance audits. This imposing financial hurdle is indeed a factor that makes the rate of adoption sluggish, predominantly in areas far from the big cities such as Riyadh and Jeddah.

Saudi Arabia Infection Control Market Competitive Landscape

The market is fragmented, with many notable players, including 3M, Getinge AB, Steris PLC, Matachana, MidMark Corporation, GE Healthcare, Stryker, STERIS, MMM Group, and Baxter International.

• New Product Launch: In March 2025, at IDS 2025, COLTENE Group introduced new dental solutions, such as advancements in endodontics, restorative dentistry, and infection control. These solutions seek to guarantee instrument sterilization, optimize workflows, and improve clinical outcomes. HySolate Liquid Dam, Kenda ShapeGuard, MicroMega One Glider & RECI Glider, Roeko Gelatamp forte & white, and BRILLIANT Lumina are among the new products. COLTENE is committed to offering dental professionals complete, superior solutions.

Saudi Arabia Infection Control Market Segmentation:

• By Product
  • Disinfectant
  • Sterilization
    • Low-temperature Sterilization
    • Heat Sterilization
    • Contract Sterilization
• By Application
  • Hospital-Acquired Infection (HAI) Prevention
  • Medical Device Sterilization
  • Pharmaceutical and Biotechnology Manufacturing
• By End-User Industry
  • Healthcare
  • Food and Beverage
  • Chemical

Table Of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK 

5. SAUDI ARABIA INFECTION CONTROL MARKET BY PRODUCT

5.1. Introduction

5.2. Disinfectant

5.3. Sterilization

5.3.1. Low-temperature Sterilization

5.3.2. Heat Sterilization

5.3.3. Contract Sterilization

6. SAUDI ARABIA INFECTION CONTROL MARKET BY APPLICATION

6.1. Introduction

6.2. Hospital-Acquired Infection (HAI) Prevention

6.3. Medical Device Sterilization

6.4. Pharmaceutical and Biotechnology Manufacturing 

7. SAUDI ARABIA INFECTION CONTROL MARKET BY END-USER INDUSTRY

7.1. Introduction

7.2. Healthcare

7.3. Food and Beverage

7.4. Chemical

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Market Share Analysis

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Competitive Dashboard

9. COMPANY PROFILES

9.1. 3M

9.2. Getinge AB

9.3. Steris PLC

9.4. Matachana

9.5. MidMark Corporation

9.6. GE Healthcare

9.7. Stryker

9.8. STERIS

9.9. MMM Group

9.10. Baxter International

10. APPENDIX

10.1. Currency 

10.2. Assumptions

10.3. Base and Forecast Years Timeline

10.4. Key benefits for the stakeholders

10.5. Research Methodology 

10.6. Abbreviations 

Companies Profiled

3M

Getinge AB

Steris PLC

Matachana

MidMark Corporation

GE Healthcare

Stryker

STERIS

MMM Group

Baxter International

Related Reports